174 related articles for article (PubMed ID: 33341849)
1. Childhood Medulloblastoma.
Mushtaq N; Resham S; Shamim S; Qureshi BM; Riaz Q; Bouffet E
J Pak Med Assoc; 2020 Nov; 70(11):2007-2016. PubMed ID: 33341849
[TBL] [Abstract][Full Text] [Related]
2. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
[TBL] [Abstract][Full Text] [Related]
3. Childhood medulloblastoma: the paradigm shift in molecular stratification and treatment profile.
Sadighi Z; Vats T; Khatua S
J Child Neurol; 2012 Oct; 27(10):1302-7. PubMed ID: 22826514
[TBL] [Abstract][Full Text] [Related]
4. [Evolution of the management of pediatric and adult medulloblastoma].
Vigneron C; Entz-Werlé N; Lutz P; Spiegel A; Jannier S; Helfre S; Alapetite C; Coca A; Kehrli P; Noël G
Cancer Radiother; 2015 Aug; 19(5):347-57; quiz 358-9, 362. PubMed ID: 26141663
[TBL] [Abstract][Full Text] [Related]
5. SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settings.
Parkes J; Hendricks M; Ssenyonga P; Mugamba J; Molyneux E; Schouten-van Meeteren A; Qaddoumi I; Fieggen G; Luna-Fineman S; Howard S; Mitra D; Bouffet E; Davidson A; Bailey S;
Pediatr Blood Cancer; 2015 Apr; 62(4):553-64. PubMed ID: 25418957
[TBL] [Abstract][Full Text] [Related]
6. The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials.
Pizer BL; Clifford SC
Br J Neurosurg; 2009 Aug; 23(4):364-75. PubMed ID: 19637007
[TBL] [Abstract][Full Text] [Related]
7. Molecular subgroups of medulloblastoma: the current consensus.
Taylor MD; Northcott PA; Korshunov A; Remke M; Cho YJ; Clifford SC; Eberhart CG; Parsons DW; Rutkowski S; Gajjar A; Ellison DW; Lichter P; Gilbertson RJ; Pomeroy SL; Kool M; Pfister SM
Acta Neuropathol; 2012 Apr; 123(4):465-72. PubMed ID: 22134537
[TBL] [Abstract][Full Text] [Related]
8. Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical Practice.
Gupta T; Shirsat N; Jalali R
Curr Pediatr Rev; 2015; 11(2):106-19. PubMed ID: 26133181
[TBL] [Abstract][Full Text] [Related]
9. Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study.
Hill RM; Richardson S; Schwalbe EC; Hicks D; Lindsey JC; Crosier S; Rafiee G; Grabovska Y; Wharton SB; Jacques TS; Michalski A; Joshi A; Pizer B; Williamson D; Bailey S; Clifford SC
Lancet Child Adolesc Health; 2020 Dec; 4(12):865-874. PubMed ID: 33222802
[TBL] [Abstract][Full Text] [Related]
10. Childhood medulloblastoma: current status of biology and treatment.
Klesse LJ; Bowers DC
CNS Drugs; 2010 Apr; 24(4):285-301. PubMed ID: 20297854
[TBL] [Abstract][Full Text] [Related]
11. Classic and desmoplastic medulloblastoma: complete case reports and characterizations of two new cell lines.
Holthouse DJ; Dallas PB; Ford J; Fabian V; Murch AR; Watson M; Wong G; Bertram C; Egli S; Baker DL; Kees UR
Neuropathology; 2009 Aug; 29(4):398-409. PubMed ID: 19077040
[TBL] [Abstract][Full Text] [Related]
12. Molecular Classification Improves Therapeutic Options for Infants and Young Children With Medulloblastoma.
Bagchi A; Dhanda SK; Dunphy P; Sioson E; Robinson GW
J Natl Compr Canc Netw; 2023 Aug; 21(10):1097-1105. PubMed ID: 37643637
[TBL] [Abstract][Full Text] [Related]
13. Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches.
Menyhárt O; Győrffy B
Cancer Metastasis Rev; 2020 Mar; 39(1):211-233. PubMed ID: 31970590
[TBL] [Abstract][Full Text] [Related]
14. Medulloblastoma in Older Adults: A Case Report and Literature Review.
Murase M; Saito K; Abiko T; Yoshida K; Tomita H
World Neurosurg; 2018 Sep; 117():25-31. PubMed ID: 29883827
[TBL] [Abstract][Full Text] [Related]
15. Magnetic Resonance Imaging in the Contemporary Management of Medulloblastoma: Current and Emerging Applications.
Dasgupta A; Maitre M; Pungavkar S; Gupta T
Methods Mol Biol; 2022; 2423():187-214. PubMed ID: 34978700
[TBL] [Abstract][Full Text] [Related]
16. Medulloblastoma: what is the role of molecular genetics?
Entz-Werle N; Carli ED; Ducassou S; Legrain M; Grill J; Dufour C
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1169-81. PubMed ID: 18588461
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical and nanoString-Based Subgrouping of Clinical Medulloblastoma Samples.
D'Arcy CE; Nobre LF; Arnaldo A; Ramaswamy V; Taylor MD; Naz-Hazrati L; Hawkins CE
J Neuropathol Exp Neurol; 2020 Apr; 79(4):437-447. PubMed ID: 32053195
[TBL] [Abstract][Full Text] [Related]
18. Medulloblastoma: From Myth to Molecular.
Ramaswamy V; Taylor MD
J Clin Oncol; 2017 Jul; 35(21):2355-2363. PubMed ID: 28640708
[TBL] [Abstract][Full Text] [Related]
19. How we treat medulloblastoma in adults.
Franceschi E; Seidel C; Sahm F; Pajtler KW; Hau P
ESMO Open; 2021 Aug; 6(4):100173. PubMed ID: 34118771
[TBL] [Abstract][Full Text] [Related]
20. Medulloblastoma: recurrence and metastasis.
Aref D; Croul S
CNS Oncol; 2013 Jul; 2(4):377-85. PubMed ID: 25054581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]